A Comparison of Methotrexate with Placebo for the Maintenance of Remission in Crohn's Disease
Top Cited Papers
- 1 June 2000
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 342 (22) , 1627-1632
- https://doi.org/10.1056/nejm200006013422202
Abstract
Patients with Crohn's disease often have relapses. Better treatments are needed for the maintenance of remission. Although methotrexate is an effective short-term treatment for Crohn's disease, its role in maintaining remissions is not known.Keywords
This publication has 32 references indexed in Scilit:
- Clinical, laboratory, radiographic, and histopathologic features of methotrexate‐associated lung injury in patients with rheumatoid arthritis. A multicenter study with literature reviewArthritis & Rheumatism, 1997
- Absence of skin sensitivity to oxides of aluminium, silicon, titanium or zirconium in patients with Crohn's disease.Gut, 1996
- Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study.Gut, 1996
- Comparison of azathioprine, methotrexate, and the combination of the two in the treatment of rheumatoid arthritisArthritis & Rheumatism, 1995
- A controlled double blind study of azathioprine in the management of Crohn's disease.Gut, 1995
- Usefulness of the american college of rheumatology recommendations for liver biopsy in methotrexate‐treated rheumatoid arthritis patientsArthritis & Rheumatism, 1995
- A controlled study of bone mineral density in patients with inflammatory bowel disease.Gut, 1995
- Frequency of glucocorticoid resistance and dependency in Crohn's disease.Gut, 1994
- Efficacy of Low-Dose Methotrexate in Rheumatoid ArthritisNew England Journal of Medicine, 1985
- Treatment of Crohn's Disease with 6-MercaptopurineNew England Journal of Medicine, 1980